Fas/FasL System In Normal Mammary Gland Development
Fas/FasL System In Normal Mammary Gland Development
批准号:
6365206
负责人:
GIL G MOR
金额:
$25.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2004-05-31
关键词:
CD95 molecule apoptosis breast neoplasms chemical carcinogenesis cytokine dimethylbenzanthracene estrogen receptors estrogens estrus gene induction /repression gene targeting genetically modified animals genistein hormone regulation /control mechanism laboratory mouse lactation leukocytes macrophage mammary epithelium mammary gland methylnitrosourea neoplasm /cancer immunology pregnancy raloxifene tamoxifen
中文摘要
描述:(由申请人提供)本提案回应
英文摘要
DESCRIPTION: (Provided by the applicant) This proposal responds to the
programmatic priorities of RFA PA 99-162 "Stages of breast development: normal
to metastatic disease." We propose to study the mechanism by which mammary
development and involution regulate the development of breast cancer. It is our
general hypothesis that programmed cell death (PCD) of mammary epithelial cells
during involution is mediated by the FasIFasL system. Others and we have
proposed that apoptosis associated with breast involution confers resistance to
tumorigenesis while inappropriate survival of the secretory epithelial cells
apparently increases susceptibility to tumor development. Accordingly,
conditions that limit proliferation or cause breast epithelial cell death could
result in reduction of risk for breast cancer in humans. Our data indicates
that the expression of Fas receptor protein on the mammary cell surface
triggers apoptosis at the end of lactation. Thus, alterations in the Fas/FasL
system may regulate the survival of proliferating cells that have the potential
for malignant transformation. It is our second hypothesis that breast cancer
may arise from the failure of the FasIFasL apoptotic pathway that would
normally eliminate aging or transformed cells that are at risk of malignant
transformation. The absence of the Fasmediated-apoptotic signal results in the
persistence of transformed cells expressing only FasL on their surface. To
prove the validity of our hypothesis we propose a four-year plan to: 1) Study
Fas and FasL expression in normal mouse mammary gland and its role in mammary
gland development and remodeling. 2) Study the role of Fas and FasL in normal
and pathologic mouse mammary gland development in Fas and FasL deficient mice.
3) To investigate the regulation of Fas and FasL expression and function; and
4) Study the regulation of FasL expression by estrogen and selective estrogen
receptor modulators (SERMs).
A thin line separates normal from neoplastic development. A delicate balance
between cell growth and cell apoptosis maintains this homeostatic state. Once
that line is breached the same genes protecting the organism from cancer may
become involved in its genesis. The genes encoding Fas and FasL, which normally
regulate homeostasis yet have the potential to foster malignant growth,
exemplify' this tenuous balance. A more thorough understanding of the function
and regulation of the genes involved in tissue homeostasis and tumor
suppression will provide valuable information related to the biology and
development of the normal mammary gland. With an improved foundation of the
normal mammary physiology, we can advance the understanding of breast cancer,
allowing the development of effective strategies for its treatment and
prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of benzene-induced MIA on fetal T cell development
-
批准号:10605881
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2023
-
负责人:GIL G MOR
-
依托单位:
Impact of BTEX Chemical Exposure During Pregnancy to Maternal and Fetal Well-Being
-
批准号:10352965
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2022
-
负责人:GIL G MOR
-
依托单位:
Impact of BTEX Chemical Exposure During Pregnancy to Maternal and Fetal Well-Being
-
批准号:10700806
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2022
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:10457235
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2019
-
负责人:GIL G MOR
-
依托单位:
Mechanisms of trophoblast-induced immune modulation
-
批准号:10226144
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2019
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:9919105
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2019
-
负责人:GIL G MOR
-
依托单位:
Mechanisms of trophoblast-induced immune modulation
-
批准号:9796318
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2019
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:9933983
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2019
-
负责人:GIL G MOR
-
依托单位:
Mechanisms of trophoblast-induced immune modulation
-
批准号:10461038
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2019
-
负责人:GIL G MOR
-
依托单位:
Mechanisms of trophoblast-induced immune modulation
-
批准号:10671640
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2019
-
负责人:GIL G MOR
-
依托单位:
Effect of polymicrobial infection on trophoblast-macrophage interactions
-
批准号:9120036
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2015
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:8308843
-
项目类别:
-
资助金额:$10.03万
-
财政年份:2012
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:9458852
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2012
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:9040230
-
项目类别:
-
资助金额:$10.03万
-
财政年份:2012
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:8442846
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2012
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:8829314
-
项目类别:
-
资助金额:$10.03万
-
财政年份:2012
-
负责人:GIL G MOR
-
依托单位:
Discovery to Cure Summer Program
-
批准号:8645666
-
项目类别:
-
资助金额:$9.75万
-
财政年份:2012
-
负责人:GIL G MOR
-
依托单位:
Function of Toll-Like Receptors Throughout Gestation
-
批准号:7629928
-
项目类别:
-
资助金额:$102.68万
-
财政年份:2009
-
负责人:GIL G MOR
-
依托单位:
Function of Toll-Like Receptors Throughout Gestation
-
批准号:8120807
-
项目类别:
-
资助金额:$104.28万
-
财政年份:2009
-
负责人:GIL G MOR
-
依托单位:
Function of Toll-Like Receptors Throughout Gestation
-
批准号:8280173
-
项目类别:
-
资助金额:$105.41万
-
财政年份:2009
-
负责人:GIL G MOR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: